Applied DNA Sciences Inc
General ticker "APDN" information:
- Sector: Health Care
- Industry: Life Sciences Tools & Services
- Capitalization: $730.0K
Applied DNA Sciences Inc does not follow the US Stock Market performance with the rate: -38.6%.
Estimated limits based on current volatility of 11.6%: low 0.17$, high 0.21$
Factors to consider:
- North and South America accounted for 91.4% of revenue in the fiscal year ended 2023-09-30
- Current price 64.9% below estimated low
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-09-30 to 2026-09-30
- 2024-09-30 to 2025-09-30 estimated range: [0.47$, 2.07$]
- 2025-09-30 to 2026-09-30 estimated range: [0.35$, 1.30$]
Short-term APDN quotes
Long-term APDN plot with estimates
Financial data
| YTD | 2022-09-30 | 2023-09-30 | 2024-09-30 |
|---|---|---|---|
| Operating Revenue | $18.17MM | $13.37MM | $3.43MM |
| Operating Expenses | $32.14MM | $24.32MM | $17.46MM |
| Operating Income | $-13.97MM | $-10.95MM | $-14.02MM |
| Non-Operating Income | $5.70MM | $0.93MM | $6.94MM |
| R&D Expense | $3.93MM | $3.74MM | $3.59MM |
| Income(Loss) | $-8.27MM | $-10.02MM | $-7.09MM |
| Taxes | $0.11MM | $-0.08MM | $0.14MM |
| Profit(Loss) | $-8.38MM | $-9.95MM | $-7.23MM |
| Stockholders Equity | $12.91MM | $4.95MM | $8.97MM |
| Inventory | $0.60MM | $0.33MM | $0.44MM |
| Assets | $22.27MM | $13.65MM | $12.79MM |
| Operating Cash Flow | $-8.98MM | $-6.22MM | $-13.71MM |
| Capital expenditure | $0.49MM | $0.08MM | $0.41MM |
| Investing Cash Flow | $-0.49MM | $-1.10MM | $-0.41MM |
| Financing Cash Flow | $18.13MM | $0.00MM | $13.40MM |
| Earnings Per Share* | $-18.68 | $-15.21 | $-1.82 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.